Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Basit Öğe Kaydı
dc.authoridTurna, Hande/0000-0003-0558-9371
dc.authoridKilickap, Saadettin/0000-0003-1637-7390
dc.authoridEralp, Yesim/0000-0001-9603-4755
dc.authoridOzyilkan, Ozgur/0000-0001-8825-4918
dc.authoridBeypınar, İsmail/0000-0002-0853-4096
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridPaydas, Semra/0000-0003-4642-3693
dc.authorwosidTurna, Hande/AAA-2972-2020
dc.authorwosidYILDIZ, IBRAHIM/JWA-6293-2024
dc.authorwosidŞenler, Filiz Çay/AAI-1824-2019
dc.authorwosidKaraoglu, Aziz/HKM-3509-2023
dc.authorwosidKilickap, Saadettin/AAP-3732-2021
dc.authorwosidDemirkazık, Ahmet/AAG-7699-2020
dc.authorwosidCoşkun, Hülya/AAH-8130-2019
dc.contributor.authorKilickap, S.
dc.contributor.authorDemirci, U.
dc.contributor.authorBugdayci, F.
dc.contributor.authorTural, D.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorPaydas, S.
dc.contributor.authorYilmaz, C.
dc.date.accessioned2024-06-12T10:51:11Z
dc.date.available2024-06-12T10:51:11Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.jtho.2019.08.1166
dc.identifier.endpageS559en_US
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue10en_US
dc.identifier.startpageS558en_US
dc.identifier.urihttps://doi.org/10.1016/j.jtho.2019.08.1166
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18273
dc.identifier.volume14en_US
dc.identifier.wosWOS:000492162203082en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal Of Thoracic Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectALK Positiveen_US
dc.subjectROS1 Positiveen_US
dc.subjectLorlatiniben_US
dc.subjectAdvanced Stage Lung Canceren_US
dc.titleLorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkeyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu